Stockreport

Myovant files U.S. application for relugolix for prostate cancer [Seeking Alpha]

Myovant Sciences Ltd. Common Shares  (MYOV) 
Last myovant sciences ltd. common shares earnings: 2/10 08:30 am Check Earnings Report
US:NYSE Investor Relations: investors.myovant.com
PDF Myovant Sciences (NYSE:MYOVmarketing applicationIt plans to file another application next month for its oral relugolix combo pill (relugolix 40 mg, estradiol 1.0 mg, and [Read more]